Thx I just have a small position to follow and will do likewise ...hold to trial readout ...unless it drops 25% from here and then I'll re evaluate . Good luck with AMRN ...werent you following how Vascepa was being used in a colon ? cancer trial . Any update on that ? Kiwi
We still hold shares of both EYPT and OCUL. My wife’s (and my)eye doctor, a retina specialist, is an investigator in the EYPT clinical trial(s). He is aware of what both companies are doing in this sector/space. We currently have no plans to sell our shares held in either company. Keep your eye on LITE, moving data at speed of light in numerous technology sectors
Market Data 
Markets 
AI
